Bayer Pharma Ag v. Aurobindo Pharma Limited

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Unassigned Judge · 2,770 cases in index

Docket number

1:25-cv-00631

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

05/21/2025

11,768 Patent cases in this court are indexed here.

Parties

• plaintiff · Bayer Pharma Ag · 88 cases
• defendant · Aurobindo Pharma Limited · 69 cases

Part of a Larger Litigation Pattern

This is one of 70 Patent cases in our index naming AUROBINDO PHARMA LIMITED — a possible mass-tort or coordinated-litigation cluster.

• Bayer Intellectual Property Gmbh v. Aurobindo Pharma Limited
  District Court, D. DelawareFiled 04/28/2017
• AbbVie Inc v. Aurobindo Pharma Limited
  District Court, D. DelawareFiled 01/13/2017
• Aurobindo Pharma Limited v. Astrazeneca Ab
  District Court, D. New JerseyFiled 08/18/2016
• Astrazeneca Ab v. Aurobindo Pharma Limited
  District Court, D. New JerseyFiled 07/20/2016
• Astrazeneca Ab v. Aurobindo Pharma Limited
  District Court, D. New JerseyFiled 07/20/2016
• Cephalon Inc v. Aurobindo Pharma Limited
  District Court, D. DelawareFiled 11/12/2015

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is Bayer Pharma Ag v. Aurobindo Pharma Limited?

Bayer Pharma Ag v. Aurobindo Pharma Limited is a federal patent lawsuit filed on 05/21/2025 in the District Court, D. Delaware. The case is currently open in the federal court system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:25-cv-00631.

When was the case filed?

Bayer Pharma Ag v. Aurobindo Pharma Limited was filed on 05/21/2025. The case is currently open.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.